Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease

Peter Socrates Creticos

Research output: Contribution to journalArticlepeer-review


Subcutaneous immunotherapy is recognized as a cornerstone in the management of allergic respiratory disease in patients who are properly characterized with allergy and with allergic rhinoconjunctivis and/or well-controlled asthma, and who are willing to adhere to the rigorous treatment program. A key tenet is that it affords the opportunity to effect long-term clinical remission through its disease-modifying properties. Furthermore, it has the potential to prevent the progression of allergic rhinitis to asthma, prevent new allergen sensitivities, and improve a patient's quality of life.

Original languageEnglish (US)
Pages (from-to)260-266
Number of pages7
JournalAllergy and Asthma Proceedings
Issue number4
StatePublished - Jul 1 2022

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease'. Together they form a unique fingerprint.

Cite this